UNI-EN 76:Current report 76 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 76 | / | 2013 | | ||||||
| Date of issue: | 2013-06-10 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 76 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time of the settlement Operation Number of shares Unit price (BGN) 04.06.2013 Buy 200 2.999 04.06.2013 Buy 500 2.999 03.06.2013 Sale 500 2.9 03.06.2013 Sale 200 2.9 03.06.2013 Sale 4000 2.91 03.06.2013 Sale 329 2.91 03.06.2013 Sale 329 2.91 03.06.2013 Sale 300 2.9 03.06.2013 Sale 500 2.9 03.06.2013 Sale 6000 2.91 03.06.2013 Sale 171 2.91 03.06.2013 Sale 171 2.91 04.06.2013 Sale 5000 2.94 04.06.2013 Sale 1000 2.945 04.06.2013 Sale 5000 2.945 04.06.2013 Sale 180 2.95 04.06.2013 Sale 500 2.99 04.06.2013 Sale 500 2.995 04.06.2013 Sale 3000 3 04.06.2013 Sale 100 3.02 04.06.2013 Sale 100 2.945 04.06.2013 Sale 100 2.95 04.06.2013 Sale 40 2.95 04.06.2013 Sale 180 2.95 05.06.2013 Sale 5000 3 05.06.2013 Sale 5000 3 05.06.2013 Sale 3500 3 06.06.2013 Sale 1000 3.01 06.06.2013 Sale 3000 3.012 06.06.2013 Sale 2000 3.01 06.06.2013 Sale 2000 3.01 06.06.2013 Sale 2000 3.01 06.06.2013 Sale 2000 3.01 06.06.2013 Sale 3000 3.015 06.06.2013 Sale 2000 3.02 06.06.2013 Sale 30 3.03 06.06.2013 Sale 110 3.01 06.06.2013 Sale 300 3.01 06.06.2013 Sale 5000 3.01 06.06.2013 Sale 3000 3.01 06.06.2013 Sale 200 3.02 06.06.2013 Sale 100 3.031 06.06.2013 Sale 300 3.04 06.06.2013 Sale 250 3.01 06.06.2013 Sale 1640 3.01 06.06.2013 Sale 650 3.01 06.06.2013 Sale 9050 3.01 06.06.2013 Sale 5000 3.01 06.06.2013 Sale 7000 3.01 06.06.2013 Sale 400 3.02 06.06.2013 Sale 200 3.031 06.06.2013 Sale 200 3.031 06.06.2013 Sale 100 3.04 06.06.2013 Sale 600 3.04 07.06.2013 Sale 400 3.03 07.06.2013 Sale 500 3.04 07.06.2013 Sale 500 3.04 07.06.2013 Sale 385 3.04 07.06.2013 Sale 894 3.05 07.06.2013 Sale 1000 3.037 07.06.2013 Sale 100 3.04 07.06.2013 Sale 515 3.04 07.06.2013 Sale 1000 3.035 07.06.2013 Sale 100 3.05 07.06.2013 Sale 6 3.05 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. Legal grounds: Art.160.4 of the Act on Trading in Financial Instruments of 29 July 2005. Signatures of individuals authorized to represent the Company: Ognian Donev | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 76 re insiders transactions.doc Current report 76 re insiders transactions.doc | Current report 76 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-06-10 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
